During the past decade, Országos Korányi TBC és Pulmonológiai Intézet conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 14 clinical trials were completed, i.e. on average, 51.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 8 clinical trials were completed. i.e. 53.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Országos Korányi TBC és Pulmonológiai Intézet" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Boehringer Ingelheim" with 4 trials sponsored, "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Amgen" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Országos Korányi TBC és Pulmonológiai Intézet" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Jazz Pharmaceuticals" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Országos Korányi TBC és Pulmonológiai Intézet" are "Carcinoma, Non-Small-Cell Lung" (14 trials), "Non-Small Cell Lung Cancer" (6 trials), "Lung Cancer" (3 trials), "Non Small Cell Lung Cancer" (3 trials) and "Non-small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Országos Korányi TBC és Pulmonológiai Intézet" in a lesser frequency.

Most popular intervention types in "Országos Korányi TBC és Pulmonológiai Intézet" are "Drug" (40 trials), "Biological" (9 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (8 trials), "Docetaxel" (6 trials), "Atezolizumab" (4 trials) and "Paclitaxel" (4 trials). Other intervention names were less common.

The vast majority of trials in "Országos Korányi TBC és Pulmonológiai Intézet" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Országos Korányi TBC és Pulmonológiai Intézet". undefined are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Országos Korányi TBC és Pulmonológiai Intézet, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Országos Korányi TBC és Pulmonológiai Intézet, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".